Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-03-15
2005-03-15
Borin, Michael (Department: 1631)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S785000, C514S012200
Reexamination Certificate
active
06867182
ABSTRACT:
A water-soluble composition containing a complex of an ionic pharmaceutically effective interleukin, characterized in that said composition contains, in addition, an amphiphilic compound, said interleukin and said amphiphilic compound forming an ionic complex, whereby the forming of the complex does not enhance the solubility of said interleukin, is suitable for increasing the activity of the interleukin and/or for the delayed release of the interleukin.
REFERENCES:
patent: 4604377 (1986-08-01), Fernandes et al.
patent: 5109038 (1992-04-01), Chauvel et al.
patent: 5124081 (1992-06-01), Vanlerberghe et al.
patent: 5650393 (1997-07-01), Pavia et al.
patent: 5665328 (1997-09-01), Horan et al.
patent: 5688761 (1997-11-01), Owen et al.
patent: 5853748 (1998-12-01), New
patent: 5952008 (1999-09-01), Backstrom et al.
patent: 179 583 (1986-04-01), None
patent: 874 048 (1998-10-01), None
patent: 917 879 (1999-05-01), None
patent: 919 618 (1999-06-01), None
patent: 947 201 (1999-10-01), None
patent: 953 576 (1999-11-01), None
patent: WO 85 04328 (1985-10-01), None
patent: WO 94 08599 (1994-04-01), None
patent: WO 95 18856 (1995-07-01), None
patent: WO 96 36352 (1996-11-01), None
patent: WO 98 21227 (1998-05-01), None
patent: WO 98 30234 (1998-07-01), None
patent: WO 98 30576 (1998-07-01), None
patent: WO 99 20298 (1999-04-01), None
Pepinsky, R, Blake; et al., The Journal of Biological Chemistry, v. 273, pp 14037-14045 (1998).
Hammerschmidt, Matthias, Trends in Genetics, 13, pp 14-21 (1997).
Tomlinson et al., J. of Colloid and Interface Science, vol. 74, No. 2, (1980), p. 349-359.
Cools et al., J. Pharm. Pharmacol., 35 (1983) p. 689-691.
Hirai et al., Int. J. Pharm., 7 (1981), p. 317-325.
Okada et al., J. of Pharm. Science, vol. 72, No. 1 (1983), p. 75-78.
Mazzenga et al., J. of Controlled Release, 16 (1991), p. 77-88.
Lee et al., Critical Rev. Therp. Drug Carrier Systems 8 (1991), p. 91-192.
Morimoto et al., Arch. Int. Pharmacodyn., 302 (1989), p. 18-26.
Aungst et al., Int. J. of Pharm., 33 (1986), p. 225-234.
Womack et al., Biochim. of Biophys. Acta, 733 (1983), p. 210-215.
Ekrami et al., FEBS Letters, 371 (1995), p. 283-286.
Marti et al., Nature, vol. 375, p. 322-325 (1995).
Yang et al., Development, vol. 124, p. 4393-4404 (1997).
Lopez-Martinez et al., Current Biology, vol. 5, p. 791-796 (1995).
Kinto et al., FEBS Letter, vol. 404, p. 319-323 (1997).
Database Caplus, DN 106:162592; Matsuda et al., JP 61293926 (1986).
Borin Michael
Hoffmann-La Roche Inc.
Johnston George W.
Remy Brian C.
Rocha-Tramaloni Patricia S.
LandOfFree
Composition of a polypeptide and an amphiphilic compound in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition of a polypeptide and an amphiphilic compound in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition of a polypeptide and an amphiphilic compound in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3409393